This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Astellas Pharma Gmbh. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Masahiro Kurotani: Innovator in Pharmaceutical Chemistry
Introduction
Masahiro Kurotani is a notable inventor based in Takahagi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on arylethenesulfonamide derivatives. His research has implications for the development of new therapeutic agents.
Latest Patents
Kurotani holds a patent for a novel crystal of arylethenesulfonamide derivative and its preparation process. The patent details the creation of crystals of a potassium salt of (E)-N-[6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]-2-phenylethenesulfonamide, along with a preparation process and novel solvates of (E)-N-[6-methoxy-5-(2-ethoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]-2-phenylethenesulfonamide. This innovation represents a significant advancement in the field.
Career Highlights
Kurotani is currently employed at Astellas Pharma GmbH, where he continues to engage in groundbreaking research. His work has been instrumental in advancing the understanding of pharmaceutical compounds and their applications.
Collaborations
Throughout his career, Kurotani has collaborated with esteemed colleagues such as Yoshinori Kato and Hironori Harada. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Masahiro Kurotani's contributions to pharmaceutical chemistry through his patent and collaborative efforts highlight his role as a key innovator in the field. His work continues to influence the development of new therapeutic agents, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
